Browsing by author "Jiménez Fonseca, Paula"

Repository

How to publish

Resources

FAQs

Now showing items 1-20 of 36

Can oncologists prompt patient prognostic awareness to enhance decision-making? Data from the neoetic study

Carmona Bayonas, Alberto; Rodríguez González, Adán; García García, Teresa; Velasco Durantez, Verónica; Hernández-San Gil, Raquel; Cruz Castellanos, Patricia; Fernández Montes, Ana; Castillo Trujillo, Alfredo; Ballester, Inmaculada; Rogado, Jacobo; Calderón, Caterina; Jiménez Fonseca, Paula (2023)
Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1a expression in parasympathetic versus sympathetic paragangliomas

Bernardo Castiñeira, Cristóbal; Sáenz de Santa María Fernández, Inés; Valdés, Nuria; Astudillo González, María Aurora; Balbín Felechosa, Milagros; Sánchez Pitiot, Ana Gloria; Jiménez Fonseca, Paula; Suárez Nieto, Carlos; Chiara Romero, María Dolores (2018)
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

Galofré Ferrater, Juan Carlos; Santamaría, Sandi J.; Capdevila, Jaume; Jiménez Fonseca, Paula (2015)
Correlación entre los datos clínico-patológicos y la expresión de los marcadores inmunohistoquímicos c-MET, IGF-1R y VEGFR-2 como factores pronósticos en el adenocarcinoma gástrico

Frunza, Ana Madalina (2017-06-23)
Description and Treatment of GEP NETs in a Spanish Hospital during 10 Years

Jiménez Fonseca, Paula; Viéitez de Prado, José María; Galván Hernández, José Alberto; Crespo Herrero, Guillermo; Frunza, Ana Madalina; Astudillo González, María Aurora; Pardo Llamas, Pilar; Izquierdo Manuel, Marta; Gutiérrez Restrepo, Eduardo; Jiménez Lacave, Ángel (2011)
Differential HIF2α protein expression in human carotid body and adrenal medulla under physiologic and tumorigenic conditions

Celada, Lucia; Cubiella, Tamara; San Juan Guardado, Jaime; San José Martínez, Andrés; Valdés, Nuria; Jiménez Fonseca, Paula; Díaz Blanco, Ignacio; Enguita González, José María; Astudillo González, María Aurora; Álvarez González, Enol; Sierra Zapico, Luisa María; Chiara Romero, María Dolores (2022)
Dynamic nature of braf or kras p.G12c mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Jiménez Fonseca, Paula; López López, Carlos; Contreras Toledo, D. (2024)
Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations

Bernardo Castiñeira, Cristóbal; Valdés, N.; Celada Crespo, Lucía; Martínez, Andrés San José; Sáenz de Santa María Fernández, Inés; Fernández Bayón, Gustavo; Fernández Fernández, Agustín; Sierra Zapico, Marta Isabel; Fernández Fraga, Mario; Astudillo González, María Aurora; Jiménez Fonseca, Paula; Rial, Juan Carlos; Hevia Suárez, Miguel Ángel; Turienzo Santos, Estrella Olga; Bernardo, Carmen; Forga, L.; Tena, I.; Molina Garrido, M. J.; Cacho, L.; Suárez Nieto, Carlos; Chiara Romero, María Dolores (2019)
Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors

Galván Hernández, José Alberto; Astudillo González, María Aurora; Vallina Álvarez, Aitana; Jiménez Fonseca, Paula; Gómez Izquierdo, Lourdes; García Carbonero, Rocío; González Meana, María Victoria (2013)
Estudio fase II con CAPIRI + Bevacizumab como tratamiento en primera línea de pacientes con cáncer colorrectal metastásico

Jiménez Fonseca, Paula (2009-06-22)
El examen MIR 2015 desde el punto de vista de la teoría de respuesta al ítem

Sánchez Lasheras, Fernando; Baladrón Romero, Jaime; Villacampa Castro, Tomás; Romeo Ladrero, José M.; Jiménez Fonseca, Paula; Curbelo, José; Fernández Somoano, Ana (2017)
Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer

Jiménez Fonseca, Paula; Solis, M. P.; Garrido, M.; Faez García, Laura; Rodríguez, David; Ruiz, A. L.; Sánchez Lorenzo, M. L.; Uriol Egido, Esther; Menéndez, M. D.; Viéitez de Prado, José María (Springer, 2015)
Gene Expression Characterization of Gastroenteropancreatic Neuroendocrine Tumors [GEPNETS: Gastrointestinal and Pancreatic nets (ginets and pnets)] and Their Correlation with Clinical Factors and Tumor Behavior

Díaz Pérez, José A.; García Carbonero, Rocío; Villabona, C.; Jiménez Fonseca, Paula (2014)
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development

García Carbonero, Rocío; García Figueiras, R.; Carmona Bayonas, Alberto; Sevilla, Isabel; Teule, Alex; Quindós, María; Grande, Enrique; Capdevila, Jaume; Aller, Javier; Arbizu, Javier; Jiménez Fonseca, Paula (Springer, 2015)
Immunohistochemical Analysis of Epithelial-Mesenchymal Transition Markers in Neuroendocrine Tumors of the Lung

Galván Hernández, José Alberto; González Meana, María Victoria; Jiménez Fonseca, Paula; Folgueras Sánchez, María Victoria; Astudillo González, María Aurora (2011)
Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer

Rodríguez González, Adán; Carmona Bayonas, A.; Hernández San Gil, R.; Cruz Castellanos, P.; Antoñanzas Basa, M.; Lorente Estelles, D.; Corral, M. J.; González Moya, M.; Castillo Trujillo, O. A.; Esteban, E.; Jiménez Fonseca, Paula; Calderón, C. (2023)
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias

Muriel López, Carolina; Esteban González, Emilio; Corral Blanco, Norberto Octavio; Jiménez Fonseca, Paula; Luque Cabal, María; Berros Fombella, José Pablo; Fernández Pérez, Yolanda; Blay Albors, Pilar; Fra Rodríguez, Joaquín; Villanueva Palicio, Noemí; Fernández de Sanmamed Gutiérrez, Miguel; Pardo Coto, Pablo; Izquierdo Manuel, Marta; Viéitez de Prado, José María; Estrada Hernández, Enrique; Jiménez Lacave, Ángel (2010)
Impacto de la mutación en KRAS y BRAF en los resultados de carcinoma colorrectal metastásico: análisis retrospectivo de un estudio multicéntrico

Contreras Toledo, Débora Corina (2024-10-31)
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)

García Carbonero, Rocío; Capdevila, Jaume; Crespo Herrero, Guillermo; Jiménez Fonseca, Paula (2010)
Management of infection and febrile neutropenia in patients with solid cancer

Virizuela Echaburu, Juan; Carratalà, J.; Aguado, J. M.; Vicente Baz, D.; Salavert, M.; Ruiz, Maribel; Ruiz, Isabel; Marco, F.; Lizasoain, M.; Jiménez Fonseca, Paula; Gudiol, C.; Cassinello, J.; Carmona Bayonas, Alberto; Aguilar, M.; Cruz, J. J. (2016)

Browsing by author "Jiménez Fonseca, Paula"

Can oncologists prompt patient prognostic awareness to enhance decision-making? Data from the neoetic study ﻿

Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1a expression in parasympathetic versus sympathetic paragangliomas ﻿

Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI) ﻿

Correlación entre los datos clínico-patológicos y la expresión de los marcadores inmunohistoquímicos c-MET, IGF-1R y VEGFR-2 como factores pronósticos en el adenocarcinoma gástrico ﻿

Description and Treatment of GEP NETs in a Spanish Hospital during 10 Years ﻿

Differential HIF2α protein expression in human carotid body and adrenal medulla under physiologic and tumorigenic conditions ﻿

Dynamic nature of braf or kras p.G12c mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? ﻿

Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations ﻿

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors ﻿

Estudio fase II con CAPIRI + Bevacizumab como tratamiento en primera línea de pacientes con cáncer colorrectal metastásico ﻿

El examen MIR 2015 desde el punto de vista de la teoría de respuesta al ítem ﻿

Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer ﻿

Gene Expression Characterization of Gastroenteropancreatic Neuroendocrine Tumors [GEPNETS: Gastrointestinal and Pancreatic nets (ginets and pnets)] and Their Correlation with Clinical Factors and Tumor Behavior ﻿

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development ﻿

Immunohistochemical Analysis of Epithelial-Mesenchymal Transition Markers in Neuroendocrine Tumors of the Lung ﻿

Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer ﻿

Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias ﻿

Impacto de la mutación en KRAS y BRAF en los resultados de carcinoma colorrectal metastásico: análisis retrospectivo de un estudio multicéntrico ﻿

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE) ﻿

Management of infection and febrile neutropenia in patients with solid cancer ﻿

Can oncologists prompt patient prognostic awareness to enhance decision-making? Data from the neoetic study

Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1a expression in parasympathetic versus sympathetic paragangliomas

Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

Correlación entre los datos clínico-patológicos y la expresión de los marcadores inmunohistoquímicos c-MET, IGF-1R y VEGFR-2 como factores pronósticos en el adenocarcinoma gástrico

Description and Treatment of GEP NETs in a Spanish Hospital during 10 Years

Differential HIF2α protein expression in human carotid body and adrenal medulla under physiologic and tumorigenic conditions

Dynamic nature of braf or kras p.G12c mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations

Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors

Estudio fase II con CAPIRI + Bevacizumab como tratamiento en primera línea de pacientes con cáncer colorrectal metastásico

El examen MIR 2015 desde el punto de vista de la teoría de respuesta al ítem

Gemcitabine plus capecitabine (Gem-Cape) biweekly in chemorefractory metastatic colorectal cancer

Gene Expression Characterization of Gastroenteropancreatic Neuroendocrine Tumors [GEPNETS: Gastrointestinal and Pancreatic nets (ginets and pnets)] and Their Correlation with Clinical Factors and Tumor Behavior

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development

Immunohistochemical Analysis of Epithelial-Mesenchymal Transition Markers in Neuroendocrine Tumors of the Lung

Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer

Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias

Impacto de la mutación en KRAS y BRAF en los resultados de carcinoma colorrectal metastásico: análisis retrospectivo de un estudio multicéntrico

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)

Management of infection and febrile neutropenia in patients with solid cancer